Medalla, Basilisa S.

HRN: 26-10-21  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/20/2024
CEFUROXIME 1.5GM (VIAL)
10/20/2024
10/27/2024
IV
1.5gm
Q8H
Multiple Soft Tissue Injury Secondary MVA
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Skin & Soft Tissue    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: